Evidence map›Paper›PMID 38204754›Full record

ArticleFrontiers in immunology2023

Allergic diseases aggravate the symptoms of SARS-CoV-2 infection in China.

Huishan Zhang, Jilei Lin, Jinhong Wu, Jing Zhang, Lei Zhang, Shuhua Yuan, Jiande Chen, Qiuyu Tang, Ailian Zhang, Yuxia Cui and 8 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 1 country.

Huishan Zhang *Department of Respiratory Medicine, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Jilei Lin *Department of Respiratory Medicine, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Jinhong Wu *Department of Respiratory Medicine, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Jing ZhangDepartment of Respiratory Medicine, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Lei ZhangDepartment of Respiratory Medicine, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Shuhua YuanDepartment of Respiratory Medicine, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Jiande ChenDepartment of Respiratory Medicine, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Qiuyu TangDepartment of Respiratory Medicine, Shanghai Children's Medical Centre Affiliated to Shanghai Jiaotong University School of Medicine, Fujian Children's Hospital, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology And Pediatrics, Fujian Medical University, Fuzhou, Fujian, China.
Ailian ZhangDepartment of Respiratory Medicine, The Second Hospital of Jiaxing, Jiaxing, Zhejiang, China.
Yuxia CuiDepartment of Respiratory Medicine, Guizhou Provincial People's Hospital, Shanghai Children's Medical Center, Shanghai JiaoTong University School of Medicine, Guiyang, Guizhou, China.
Xiaojuan XuDepartment of Respiratory Medicine, Shaoxing Central Hospital, Shaoxing, Zhejiang, China.
Hongxie DaiDepartment of Respiratory Medicine, Zhoupu Hospital Affiliated to Shanghai University of Medicine & Health Sciences, Shanghai, China.
Hongbo ShiDepartment of Respiratory Medicine, Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang, China.
Xiaowei HuDepartment of Respiratory Medicine, Shanghai Children's Medical Centre Affiliated to Shanghai Jiaotong University School of Medicine, Fujian Children's Hospital, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology And Pediatrics, Fujian Medical University, Fuzhou, Fujian, China.
Dan XieDepartment of Respiratory Medicine, Sanya Women and Children's Hospital Affiliated to Hainan Medical College, Shanghai Children's Medical Center, Sanya, Hainan, China.
Jing ChenDepartment of Respiratory Medicine, Linyi Maternal and Child Healthcare Hospital, Linyi, Shandong, China.
Fengquan HeHongHe MCH (HongHe Hani and Yi Autonomous Prefecture Maternal and Child Health Hospital), Honghe, Yunnan, China.
Yong YinDepartment of Respiratory Medicine, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Shanghai Jiao Tong University · CNFujian Medical University · CNNingbo Medical Center Lihuili Hospital · CNShanghai Children's Medical Center · CNShanghai University of Medicine and Health Sciences · CNYunnan Maternal and Child Health · CN

Funding

CSRD VA I01 CX000101
6 · The paper itself

Abstract

Background: The relationship between allergic diseases and the adverse outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been a subject of controversy. This study aimed to investigate the association between allergic diseases and the incidence and severity of symptoms in SARS-CoV-2 infection. Methods: Clinical data of individuals, including children and their parents, infected with SARS-CoV-2 from December 2022 to January 2023 in China were retrospectively analyzed. The data were collected through questionnaires. Statistical analysis, including chi-squared tests, nonparametric analysis, one-way ANOVA, and logistic regression analysis, was used to examine the relationship between allergic diseases, prior medication, and the symptoms of SARS-CoV-2 infection. Results: There were 3,517 adults and 3,372 children with SARS-CoV-2 infection included in the study. Fever was found to occur at similar rates in children (86.5%) and adults (86.8%). However, other symptoms related to respiratory issues (such as cough and sore throat), neurological symptoms (headache, loss of smell, and loss of taste), and systemic symptoms (muscle soreness and weakness) were observed more frequently in adults ( Conclusions: Both children and adults with allergic diseases were found to be more prone to experiencing symptoms of SARS-CoV-2 infection, and these symptoms tended to be more severe.

Indexed as

COVID-19Rhinitis, AllergicAdultChildChinaHumansRetrospective StudiesSARS-CoV-2allergic rhinitisasthmaatopic dermatitisincidence of symptomsSARS-CoV-2 infectionseverity of symptoms

Identifiers

PMID38204754
PMCPMC10777727
OpenAlexW4390111205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.